REQUEST A DEMO
Total
USD $0.00
Search more companies

Grex Pharma Sas (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Grex Pharma Sas Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Grex Pharma Sas is based in Colombia, with the head office in Bogota D.C.. The enterprise operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The company was established on May 20, 2013. The total number of employees is currently 2 (2016). In its most recent financial highlights, the company reported a net sales revenue increase of 65.55% in 2023. During that time, Grex Pharma Sas’s total assets grew by 97.22%.

Headquarters
Cr 19 # 84 - 09
Bogota D.C.; Bogota D.C; Postal Code: 0813

Contact Details: Purchase the Grex Pharma Sas report to view the information.

Basic Information
Total Employees:
Purchase the Grex Pharma Sas report to view the information.
Outstanding Shares:
Purchase the Grex Pharma Sas report to view the information.
Incorporation Date:
May 20, 2013
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Company Performance
Financial values in the chart are available after Grex Pharma Sas report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
65.55%
Total operating revenue
65.55%
Operating profit (EBIT)
N/A
Net Profit (Loss) for the Period
N/A
Total assets
97.22%
Total equity
N/A
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
2058.5%
Quick Ratio
34.67%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?